White House nominates Pennsylvania Rep. Tom Marino to lead Office of National Drug Control Policy

Error message

In order to filter by the "in queue" property, you need to add the Entityqueue: Queue relationship.

On September 1, the Trump Administration announced plans to nominate Rep. Tom Marino (R-Pa.) to lead the White House’s Office of National Drug Control Policy (ONDCP).   

Rep. Marino, who has served in Congress since 2011, previously worked as Lycoming County’s District Attorney between 1992-2002 and later as a federal prosecutor for Pennsylvania’s Middle District. In Congress, Rep. Marino is known as a vocal advocate for addressing the opioid epidemic through supply-side drug control policies, and in 2016, he was appointed by House Speaker Paul Ryan (R-Wis.) to serve on the Bipartisan Heroin Task Force to produce legislation to combat the opioid epidemic.

In 2015, Rep. Marino introduced two bills – H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act and H.R. 3380, the Transnational Drug Trafficking Act – that ultimately became law.

The Office of National Drug Control Policy is responsible for coordinating the development and implementation of U.S. drug control policies. In addition, the office supports the White House’s Commission on Combating Drug Addiction and the Opioid Crisis and administers grant programs, such as the High Intensity Drug Trafficking Areas Program and Drug-Free Communities. The office’s director serves as a chief advisor to the president on drug-related issues.

Rep. Marino’s nomination will be subject to a simple majority vote in the U.S. Senate. If confirmed, his appointment will prompt a special election in Pennsylvania’s 10th District.

NACo will continue to monitor these presidential appointments and work with our federal partners to ensure that county interests are represented in national drug policymaking.

Additional NACo resources:

Related Posts

Related Resources